South Korea

Daewoong Pharmaceutical Seeks Approval for Fexuprazan in China's Anti-Ulcer Drug Market

Daewoong Pharmaceutical's domestically produced drug no. 34 Fexuprazan, a newly developed one for the treatment of gastroesophageal reflux disease (GERD), ...

 July 31, 2023 | News

GC Genome Enables Prognosis Prediction and Targeted Treatment in Breast Cancer

  ''We can gain vital insights into patient prognosis and make informed decisions regarding the most effective treatment strategies through ctDNA CNA...

 July 27, 2023 | News

South Korea's GC Biopharma's 'GC FLU' Vaccine Approved in Egypt

Striving to further expand its territory to Africa and the Middle East from Southeast Asia and Latin America "Will cr...

 July 24, 2023 | News

US FDA Grants Orphan Drug Designation to SN Bioscience's 'SNB-101' for Small Cell Lung Cancer

SNB-101 showed excellent efficacy in animal small cell lung cancer models, and based on this, it has been designated as an orphan drug by the US FDA after ...

 July 21, 2023 | News

Samsung Biologics releases 2023 ESG Report

Samsung Biologics (KRX: 207940), a global contract development and manufacturing organization (CDMO), today released its 2023 Environmental, Social an...

 July 19, 2023 | News

BIORCHESTRA Wins Grand Prize in 2023 Merck Advance Biotech Grant Program

Recognition of outstanding in-vivo outcomes from a lead RNA program in CNS Underpinned by proprietary IV-formulated, Brain-targeting Ribonucleic Ac...

 July 18, 2023 | News

SK Biopharmaceuticals Makes Big Bets to be 'Big Biotech'

SK Biopharmaceuticals CEO Donghoon Lee maps out its medium to long-term strategy at a press conference SK Biopharmaceuticals mobilizes its cutti...

 July 18, 2023 | News

3D bioprinting technology to be used for removing cancer cells

  □ A three-dimensional (3D) bioprinting technology capable of eliminating cancer cells using the function of immune cells has been developed for t...

 July 11, 2023 | News

Transcenta Receives Approvals for Global Phase III Trial of Osemitamab (TST001)

To initiate TranStar 301 global Phase III pivotal trial of Osemitamab (TST001) in combination with Nivolumab and chemotherapy for the first-line treatment ...

 July 10, 2023 | News

GeneQuantum Healthcare and Aimed Bio collaborate to develop 5 innovative ADC drugs

Since April of last year, GeneQuantum and Aimed Bio have been collaborating on the joint development of a FGFR3-targeting ADC named GQ1011/AMB302. The prog...

 July 07, 2023 | News

Brii Biosciences Expands Hepatitis B Leadership with Comprehensive Portfolio from Prevention to Cure

Company also acquires exclusive rights to PreHevbri®, a clinically differentiated, 3-antigen prophylactic vaccine, from VBI in Greater China ...

 July 06, 2023 | News

SK Bioscience and Government Pharmaceutical Organization Strengthen Vaccine Infrastructure in Thailand

SK bioscience and the Government Pharmaceutical Organization agreed to establish a pandemic response platform, encompassing not only Thailand but extendi...

 July 05, 2023 | News

Lunit's AI Solution Impacts Radiologists' Lung Cancer Diagnosis - Published in Radiology

Findings from a recent study demonstrate that medical AI solutions with only high diagnostic accuracy can significantly improve the reading performance of ...

 July 04, 2023 | News

Zymedi Collaborates with National Heart, Lung, and Blood Institute to Develop ZMA001 mAb for PAH Treatment

  The CRADA between Zymedi and the NHLBI will enable the organizations to collaborate together to advance the development of ZMA001. Zymedi will work...

 July 03, 2023 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close